About
Mr. Christopher P. Kiritsy co-founded Arisaph Pharmaceuticals, Inc. in 1999 and has been its Chief Executive Officer & President since June 2005. Mr. Kiritsy served as Consultant of Kos Pharmaceuticals Inc. since May 23, 2005. He served as an Executive Vice President, Corporate Development and Chief Financial Officer of Kos Pharmaceuticals Inc., until May 20, 2005. He served as Senior Vice President of Kos Pharmaceuticals Inc. He played a key operating role in commercializing Kos' two internally developed cholesterol therapies (Niaspan® and Advicor®). In 1999, while serving as Director of Business Planning at Kos Pharmaceuticals, a non-executive officer position, and before Kos Pharmaceuticals conducted business with Triad, Mr. Kiritsy acted as advisor to Mr. Jaharis in connection with his initial investment in Triad. He is a seasoned entrepreneur and possesses 17 years of unique business and technical experience, previously holding senior management positions in R&D and general manag
Position in the VCSift Database
- • 5 investors at Vatera Healthcare Partners are tracked.
- • 672 investors hold the Director role in VCSift. Christopher P. Kiritsy is one of them.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
Contact Information
Find more investors like Christopher
Search Investors